Učitavanje...
Tuberculosis innovations mean little if they cannot save lives
The past decade has seen the emergence of new diagnostics and drugs for tuberculosis, a disease that kills over 1.8 million people each year. However, these new tools are yet to reach scale, and access remains a major challenge for patients in low and middle income countries. Urgent action is needed...
Spremljeno u:
| Izdano u: | eLife |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
eLife Sciences Publications, Ltd
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5413344/ https://ncbi.nlm.nih.gov/pubmed/28460659 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7554/eLife.25956 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|